Pericardial Resection to Treat Heart Failure
NCT03073668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2019-05-14
Summary
The researchers are doing this study to find out whether there will be less increase in cardiac filling pressure after the surgeon opens the pericardium (the membrane around the heart) than when the pericardium is intact. The researchers want to see whether opening the pericardium is an effective way to reduce the blood filling pressures in the heart.
Conditions
Interventions
- PROCEDURE
-
Anterior pericardiotomy
The surgical team will perform anterior pericardiotomy. This will not be a complete pericardiectomy but rather a limited anterior incision to gain access to the heart for surgical exposure.
- DRUG
-
Saline
During the measurement of cardiac hemodynamic tests, a saline bolus of 300 ml will be administered over 1-2 minutes.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Barry A Borlaug · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-20
- Primary Completion
- 2018-01-23
- Completion
- 2019-02-02
Countries
- United States
Study Locations
More Related Trials
-
Spironolactone in Atrial Fibrillation
NCT02673463 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Nesiritide in Diastolic Heart Failure.
NCT00309868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction
NCT05849766 ·Status: COMPLETED ·Phase: PHASE3
-
Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation
NCT02764619 ·Status: UNKNOWN ·Phase: PHASE3
-
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
NCT05600387 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
CD-NP in Subjects With Stable Chronic Heart Failure
NCT00620308 ·Status: COMPLETED ·Phase: PHASE1
-
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
NCT06955260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
NCT00252187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antiarrhythmic Effects of Spironolactone in Patients With ICDs
NCT04495712 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Active VItamin D on Left Atrial Volume Index
NCT01630408 ·Status: WITHDRAWN ·Phase: NA
-
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
NCT03030235 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults
NCT04996719 ·Status: COMPLETED ·Phase: PHASE1
-
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
NCT01354613 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
NCT01932606 ·Status: COMPLETED ·Phase: PHASE2
-
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)
NCT00729222 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Effects of Methylprednisolone and Prednisolone on the Risk of Acute Decompensated Heart Failure - An Emulated Target Trial
NCT06468007 ·Status: COMPLETED
-
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
NCT03030222 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Nesiritide in the Management of Acute Diastolic Heart Failure
NCT00083772 ·Status: TERMINATED ·Phase: PHASE4
-
Cell Therapy In Dilated Cardiomyopathy
NCT00333827 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Inflammation in Heart Failure
NCT05330013 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Vericiguat on Hemodynamics of Heart Failure
NCT05704478 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Sacubitril-Valsartan on Cardiac Structure and Function
NCT06693674 ·Status: RECRUITING ·Phase: PHASE3
-
Dapagliflozin With or Without Spironolactone for HFpEF
NCT05676684 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
NCT06039072 ·Status: UNKNOWN